A ground-breaking public sector data programme is being supercharged with a £168 million investment to improve lives across the UK. ADR UK (Administrative Data Research UK) has already helped deliver pay rises for millions, improved education outcomes, and reduced reoffending through linked public sector data, and it is working with Cancer Research UK to support early cancer diagnosis research. ADR UK links deidentified administrative data for accredited researchers to unlock powerful insights and support evidence-based policymaking—improving health, justice, education, and economic outcomes. The investment ensures the UK remains a global leader in trusted data access, infrastructure and research for the public good. Find out more: https://lnkd.in/eS-WQ3DV
£168m boost for ADR UK to improve UK lives
More Relevant Posts
-
The K Scholars Program at UCSF is pivotal in advancing clinical science. The LSP Family Foundation is proud to support participating researchers whose work is furthering patient care and health systems, particularly in the fields of mental health and children’s and maternal health. The K Scholars’ work deepens our understanding of science and health care, and ensures that discoveries translate into equitable, evidence-based care for communities everywhere. We are especially proud to have supported the research of Dr. Erin C. Accurso, Ph.D., Clinical Director of the UCSF Eating Disorders Program, whose work is transforming access to effective and high-quality care for young people with eating disorders, particularly those served by Medicaid. Dr. Accurso’s innovative models for sustainable, community-based care exemplify the leadership and impact that University of California, San Francisco's K Scholars Program makes possible. Thank you to Dr. Vanessa Jacoby, Dr. Urmimala Sarkar MD MPH, Madeline Mann, and the entire UCSF team for shepherding the K Scholars Program. At the LSP Family Foundation, we are honored to help advance this mission—and to champion UCSF’s extraordinary community of clinician-scientists who are improving health outcomes for generations to come.
To view or add a comment, sign in
-
Important story here. Not just related to Harvard but many other US Public Health (and Medical) Schools and Research Institutes. Highlights a fundamental problem with science funding: grant-dependent "soft money" funding and the environment it perpetuates. I have been astounded my entire career how various stakeholders haven't pushed for reform of the soft money system that made these schools vulnerable for ages to such a Trump admin (pointless) defunding move. Universities long knew they should properly invest for financial sustainability of these schools but didn't. Also, elected officials & fed appointees like NIH chiefs could have instituted funding requirement reforms decades ago but didn't. Plus, as anyone in the health sciences knows, this grant-dependent system creates a culture that exploits faculty and prioritizes grant getting (and dollars) vs. doing the best science (and thus is antithetical to what grants and universities are supposed to promote). Many talented people in my network have been negatively affected by this system over the years and now even more so with these needlessly severe Trump administration cuts. It's cliche to say that crisis presents opportunity, but let's hope (as taxpayers, beneficiaries of scientific discovery, whatever) that whatever systems eventually result from this pointless, tragic mess (no fix anytime soon) make these schools more sustainable and thus resilient to such efforts, enabling US faculty and other researchers to continue to do excellent work. https://lnkd.in/eTmgaRkK
To view or add a comment, sign in
-
AMCs push to protect research from financial headwinds Sustaining world-class research amid margin pressures requires sharper focus and strategic recruitment, academic health system leaders told Becker’s. https://buff.ly/c4RWw3x
To view or add a comment, sign in
-
AMCs push to protect research from financial headwinds Sustaining world-class research amid margin pressures requires sharper focus and strategic recruitment, academic health system leaders told Becker’s. https://buff.ly/c4RWw3x
To view or add a comment, sign in
-
AMCs push to protect research from financial headwinds Sustaining world-class research amid margin pressures requires sharper focus and strategic recruitment, academic health system leaders told Becker’s. https://buff.ly/c4RWw3x
To view or add a comment, sign in
-
There's a lot of talk in the press about industry's investment in UK research, and rightly so. But this report, a joint venture between Wellcome Trust, Frontier Economics and Association of Medical Research Charities emphasises why research funded by academic institutions, public health bodies, charities, or government agencies - so called non-commercial clinical research - is just as important. As well as the triple dividend Beth outlines, unlocking growth, supporting the NHS, and improving people's lives, research funded solely for public interest enables industry funded research. That being said, why don't we stop referring to this research by what it isn't? Perhaps change non-commercial clinical research to Public Interest Clinical Research? Or Civically Funded Clinical Research? Would love to hear people's thoughts. Well done to colleagues at AMRC and Frontier Economics for a great report.
A new report, commissioned by the AMRC and Wellcome Trust, has found that non-commercial clinical research contributed £72.7bn to the UK economy between 2014 and 2024. The analysis, by Frontier Economics, explores the extensive benefits of non-commercial clinical research, revealing the ‘triple dividend’ it brings to the UK: 🔶 unlocking growth 🔶 supporting the NHS 🔶 improving lives Read more ⬇️ https://bit.ly/3KrW7nf
To view or add a comment, sign in
-
💡 IS-PEC Talks with Sabina De Geest: Implementation Science as a Team Sport What happens when #research stops chasing impact factors and starts creating impact in real-world settings? In this powerful conversation, Moriah Ellen speaks with Professor Sabina De Geest, Professor of #Nursing at the University of Basel and KU Leuven, global leader in health systems research, and founder of the Swiss Implementation Science Network (IMPACT). From her work leading the PIONEER Research Group to co-founding Switzerland’s national implementation network, Sabina shares how behavioral, psychosocial, and e-health innovations can actually change population outcomes. 🎧 Listen as she takes us inside the mindset shift that’s transforming research worldwide: → Why implementation science begins long before the paper is published → How bringing researchers, clinicians, and patients together fuels sustainability → Why health-economic analysis isn’t optional, it’s essential for policy uptake → How system science and team-based thinking can shorten the runway from evidence to impact 🧠 “Implementation science is team sport. It takes a long runway but it’s how you get a jumbo jet off the ground.” From frailty prevention in community care to re-imagining academic reward systems, Sabina shows us what it looks like when we stop asking ‘what works?’ and start asking ‘what works, for whom, and why?’ 📣 What’s one collaboration or system-science approach you’ve seen that really accelerated implementation? Share it below, we’re gathering examples for upcoming IS-PEC Talks. Is there someone YOU 🫵 want to hear from? Let us know in the comments! 🔗 Full interview here: https://lnkd.in/gtK8mJw9 #ISPECTalks #SabinaDeGeest #ImplementationScience #HealthSystems #BehavioralScience #TeamScience #HealthEconomics #SystemScience #EHealth #ChronicCare #EvidenceToAction #ISPEC #IMPACT #PIONEER
To view or add a comment, sign in
-
Earlier this year, we released our report mapping the growing UK ecosystem working to solve ME/CFS and Long COVID - in collaboration with the wonderful #ThereForME 🌱🇬🇧 Today we are showcasing the ME/CFS researchers! 💙 We want to highlight this ecosystem to show that there *is* hope, as world-class researchers in the UK work to unravel these devastating diseases. At the same time, we also want to emphasise to policymakers that public support is vital to accelerate the fundamental research that has been so deprived for so long. Life sciences are a key strength of the UK economy, and this can act as a basis for UK startups and companies bringing diagnostics, treatments and ultimately cures to a huge global population (400m+) desperate for solutions! 🌎📈 #MECFS #LongCovid
To view or add a comment, sign in
-
PubMed Carries a Warning Notice! Due to a lapse in US government funding, PubMed updates may be delayed, new submissions may not be processed, and queries may go unanswered until funding is restored. While the NIH Clinical Center remains open, a prolonged funding gap could impact the flow of new research evidence and timely access to updates. For researchers and students who rely on PubMed daily, this is a strong reminder that sustained support for global knowledge resources is essential. 🔍 Research doesn’t stop — but access to it can. 🌐 www.qmed.ngo #QMed #PubMed #ResearchAccess #MedicalResearch #EvidenceBasedMedicine
To view or add a comment, sign in
-
-
PubMed Carries a Warning Notice! Due to a lapse in US government funding, PubMed updates may be delayed, new submissions may not be processed, and queries may go unanswered until funding is restored. While the NIH Clinical Center remains open, a prolonged funding gap could impact the flow of new research evidence and timely access to updates. For researchers and students who rely on PubMed daily, this is a strong reminder that sustained support for global knowledge resources is essential. 🔍 Research doesn’t stop — but access to it can. 🌐 www.qmed.ngo #QMed #PubMed #ResearchAccess #MedicalResearch #EvidenceBasedMedicine
To view or add a comment, sign in
More from this author
Explore related topics
Explore content categories
- Career
- Productivity
- Finance
- Soft Skills & Emotional Intelligence
- Project Management
- Education
- Technology
- Leadership
- Ecommerce
- User Experience
- Recruitment & HR
- Customer Experience
- Real Estate
- Marketing
- Sales
- Retail & Merchandising
- Science
- Supply Chain Management
- Future Of Work
- Consulting
- Writing
- Economics
- Artificial Intelligence
- Employee Experience
- Workplace Trends
- Fundraising
- Networking
- Corporate Social Responsibility
- Negotiation
- Communication
- Engineering
- Hospitality & Tourism
- Business Strategy
- Change Management
- Organizational Culture
- Design
- Innovation
- Event Planning
- Training & Development
--
3moResearch productivity must be demonstrated to prove the value of taxpayers money. Many public-funded projects falsely claimed the originality and novelty (eg claiming to be groundbreaking) but eventually had very low number of outputs. These are not ambitious and a clear sign of fraudulent claims for scientific breakthroughs. If fact these are the waste of taxpayers money and must not be repeated.